Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01218971Phase 3Completed
A Phase 3 trial of naltrexone in alcohol dependence, sponsored by Alkermes. Started Aug 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01218971.